access

Views & Analysis

On the pulse of ASCO: pricing and clinical trial access

New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.

News

Many patients still denied cancer drugs in UK, survey finds

The Institute for Cancer Research has called for action to improve access to innovative cancer treatments after a new survey found that many UK patients are being denied drugs and see the p

Views & Analysis

Cost concerns with the new NHS pricing scheme

A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.

White Papers

Thinking niche: the challenge of pharma's focus on small pat...

With the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche disease areas, what is the impact and therefore change of requirement in terms of

Partner Content

Partner Content

Industry experts set to transform evolving pre-approval & un...

Created in response to unprecedented global demand from patients and physicians and to provide a long-sought after alternative for the biopharma

Views & Analysis

A healthy discussion on funding tomorrow’s treatments

The adage 'do more with less' is of increasing relevance to global economies, with governments under pressure to cut and compress public spend yet simultaneously increase both productivity and

On the pulse of ASCO: pricing and clinical trial access

Many patients still denied cancer drugs in UK, survey finds

Cost concerns with the new NHS pricing scheme

Thinking niche: the challenge of pharma's focus on small pat...

Industry experts set to transform evolving pre-approval & un...

A healthy discussion on funding tomorrow’s treatments

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

access

Editor's Picks